| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_33b6fba4cf0945c0cebfceff0db8d383 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0051
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5575 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-00 |
| filingDate |
2016-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_677106561f0a0f74ebc692e9f4539b76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f6bd8a610669e4ffebe0660c90c58bc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b976a46991dd75d56d103b47b405c9b0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06bade679c3e8ab5519cca284795eaf9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_47323366096129ad684d3a35dd90ff43 |
| publicationDate |
2018-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3283004-A1 |
| titleOfInvention |
Ocular insert composition of semi-crystalline or crystalline pharmaceutically active agent |
| abstract |
The present disclosure includes compositions of a semi-crystalline or crystalline pharmaceutically active agent dispersed in a polymer matrix, in which the active agent is less degraded and, therefore, has lower level of impurities. The present disclosure further includes a method of reducing or preventing physical and chemical degradation of a semi-crystalline or crystalline active agent pharmaceutically active agent dispersed in a polymer matrix. A method of preparation of the composition is also included in this disclosure. |
| priorityDate |
2015-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |